Medipee | Updates

By Thomas Prokopp

Medipee in the Finals of the Healthy Hub Initiative

Public
Public

Dear Companists,

As mentioned in the third update, the Healthy Hub contests offers young companies the opportunity to test their solutions in the direct vicinity of statutory health insurance companies.

We are in the finals of the competition and will present our concept in mid-March. A total of 15 finalists were invited to Berlin, of which 5 will be selected. A jury of experts from a variety of departments in the health insurance companies will make the final selection. Keep your fingers crossed for us.

 

Information about the Healthy Hub Initiative:

Five health insurance companies – BIG direkt gesund, HEK Hanseatische Krankenkasse, IKK Südwest, mhplus Betriebskrankenkasse, and SBK Siemens Betriebskrankenkasse – came together for the Healthy Hub Initiative to pave the way for innovative ideas in the primary health care market.

The Healthy Hub gives founders the chance to test their solutions’ market viability within the health insurance companies’ daily operations.

The insurance companies carry the cover the cost of the products' performance during the test phase. This gives participants the chance to earn money during the test phase.

 

Healthy Hub Initiative

You can find more information here: http://www.healthy-hub.de/index.php/home-17.html

 

With kind regards,

Your Medipee team



Comments

Only registered Companists can comment. Please log in to leave a comment.

Note

Investments in crowdfunding projects offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, these investments are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by splitting their investment amount between crowdfunding campaigns rather than investing all of it in one crowdfunding campaign. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the Companists are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the Companists – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, crowdfunding investments are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 174,200

Invested

279

Companists

12.28 %

Share Offered

Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used.

Follow us

Contact Us
Your contact for all questions about investing on Companisto:
Sascha Jung
Investor Relations

Toll-free phone number for investors

0800 - 100 267 0 (DE)
0800 - 100 267(AT / CH)

Service hours Mo-Fr 9 a.m.- 7 p.m.

Companisto GmbH
Köpenicker Str. 154
10997 Berlin
Newsletter
Der E-Mail-Newsletter ist jederzeit mit einem Klick abbestellbar.
Source: Own research. Based on data from the German Private Equity and Venture Capital Association - BVK, among others.
Investor Support
Please register in order to see the complete profile of Medipee.
Already registered?    Log in